Article
Modality has antibacterial activity against P. acnes and an independent,potent anti-inflammatory effect
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Peter Lio, MD, Advocates for Personalized Pediatric Dermatology
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Can Colloidal Oat Emollients Be Used to Treat Pediatric Atopic Dermatitis?
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
New Qtorin Rapamycin Data Featured at World Congress of Pediatric Dermatology
Icotrokinra Demonstrates Efficacy in Adolescents and Adults With Moderate to Severe Psoriasis in ICONIC-LEAD Phase 3 Study
New Guidance Aims to Improve Genital Psoriasis Treatment
IL-23 and IL-17 Inhibitors Reduce Cardiovascular Outcomes in Statin-Treated Psoriasis Patients
Lurie Children’s Becomes First Treatment Center for Zevaskyn Gene Therapy in Patients with RDEB
Artax Biopharma's AX-158: A Novel Approach to T Cell-Driven Inflammation in Psoriasis